Drugs for the treatment of pulmonary arterial hypertension
- Status:
- Discontinued
- Technology type:
- Medicine
- Decision:
- Prioritised
- Process:
- TA
- ID number:
- 12
- Referral date:
- 01 April 2005
- Topic area
- Cardiovascular, Therapeutic procedures
Provisional Schedule
- Consultation on draft scope by stakeholders::
-
October 2006
- Closing date for invited submissions / evidence submission::
- 10 May 2007
- Final scope published::
- January 2007
- 1st appraisal committee meeting::
- 03 October 2007
- 2nd appraisal committee meeting::
- 05 February 2008
- 3rd appraisal committee meeting::
- 03 April 2008
Project Team
- Assessment Group / Evidence Review Group:
- West Midlands Health Technology Assessment Collaboration
- Communications manager:
- Kristin O'Leary
- Executive Lead:
- Peter Littlejohns
- Project manager:
- Jeremy Powell
- Technical Lead:
- Helen Knight
Email enquiries
If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 27 May 2005 | Topic summary published. |
| 17 October 2007 | Timelines extended to accommodate additional analysis requested by the committee. Second committee meeting rescheduled. |
| 09 November 2007 | Request to stakeholders seeking additional observational or registry data on the survival benefit provided by the drugs that are subject to this appraisal. |
| 28 October 2008 | Consultees and commentators were invited to comment on a revised remit, scope and provisional matrix |
| 25 November 2008 | Closing date for comment on draft scope, remit and matrix |
| 30 March 2009 | The appraisal was removed from the NICE work programme |
For further information on our processes and methods, please see our CHTE processes and methods manual